Modification and Uptake of a Cisplatin Carbonato Complex by Jurkat Cells
Open Access
- 21 April 2006
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 70 (1), 348-355
- https://doi.org/10.1124/mol.106.023184
Abstract
The interactions of Jurkat cells with cisplatin, cis-[Pt(15NH3)2Cl2](1), are studied using 1H-15N heteronuclear single quantum coherence (HSQC) NMR and inductively coupled plasma mass spectrometry. We show that Jurkat cells in culture rapidly modify the monocarbonato complex cis-[Pt(15NH3)2(CO3)Cl]- (4), a cisplatin species that forms in culture media and probably also in blood. Analysis of the HSQC NMR peak intensity for 4 in the presence of different numbers of Jurkat cells reveals that each cell is capable of modifying 0.0028 pmol of 4 within ∼0.6 h. The amounts of platinum taken up by the cell, weakly bound to the cell surface, remaining in the culture medium, and bound to genomic DNA were measured as functions of time of exposure to different concentrations of drug. The results show that most of the 4 that has been modified by the cells remains in the culture medium as a substance of molecular mass 4, which is present in the culture medium, so it cannot bind to the cell. Because there is only a slow decrease in the amount of unmodified 4 remaining in the culture medium after 1 h, -1.1 ± 0.4 μM h-1, the cells subsequently lose their ability to modify 4. These observations have important implications for the mechanism of action of cisplatin.This publication has 22 references indexed in Scilit:
- Formation of monofunctional cisplatin-DNA adducts in carbonate bufferJournal of Inorganic Biochemistry, 2006
- Activation of Carboplatin by CarbonateChemical Research in Toxicology, 2005
- Cisplatin Carbonato Complexes. Implications for Uptake, Antitumor Properties, and ToxicityJournal of the American Chemical Society, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Experimental and Theoretical Studies on the Pharmacodynamics of Cisplatin in Jurkat CellsChemical Research in Toxicology, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Impaired hydrolysis of cisplatin derivatives to aquated species prevents energy-dependent uptake in GLC4 cells resistant to cisplatinJBIC Journal of Biological Inorganic Chemistry, 2003
- The Mechanism of Action of Cisplatin: From Adducts to ApoptosisPublished by Wiley ,1999
- Drug accumulation and DNA platination in cells exposed to aquated cisplatin speciesCancer Letters, 1994
- Use of a trypan blue assay to measure the deoxyribonucleic acid content and radioactive labeling of viable cells.Journal of Histochemistry & Cytochemistry, 1980